Psoriatic Arthritis News and Research

RSS
Like rheumatoid arthritis (RA), psoriatic arthritis is a chronic inflammatory disease of the joints and connective tissue. The disease causes joint pain and swelling that can lead to crippling along with inflamed and irritated scaly red patches of skin throughout the body. It is a progressive and debilitating disease and because there are no treatments specifically approved for psoriatic arthritis, doctors often use therapies approved for RA, including nonsteroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). However, no DMARDs are currently approved for use in psoriatic arthritis. There are approximately 300,000 patients with psoriatic arthritis in the United States and the disease affects both men and women most commonly between the ages 30 and 50. Psoriatic arthritis patients are generally treated by rheumatologists and dermatologists.
Age of psoriasis onset decides if the skin or joints act up first

Age of psoriasis onset decides if the skin or joints act up first

Methotrexate reduces joint damage in hand osteoarthritis

Methotrexate reduces joint damage in hand osteoarthritis

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

Healthiest gut bacteria with plant-based or Mediterranean diet

Healthiest gut bacteria with plant-based or Mediterranean diet

Diagnostic value of ultrasound in comparing different types of arthritis

Diagnostic value of ultrasound in comparing different types of arthritis

Study shows link between BMI and disease severity in psoriatic arthritis

Study shows link between BMI and disease severity in psoriatic arthritis

Finding potential treatments for autoimmune diseases

Finding potential treatments for autoimmune diseases

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

ACR and NPF release joint treatment guideline for psoriatic arthritis

ACR and NPF release joint treatment guideline for psoriatic arthritis

NPF grants support advancement of psoriatic disease research

NPF grants support advancement of psoriatic disease research

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Price check on drug ads: Would revealing costs help patients control spending?

Price check on drug ads: Would revealing costs help patients control spending?

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Study: Psoriasis patients taking Humira show no change in aortic inflammation

Study: Psoriasis patients taking Humira show no change in aortic inflammation